C4 Therapeutics Inc. (CCCC)
NASDAQ: CCCC
· Real-Time Price · USD
2.46
0.11 (4.68%)
At close: Aug 15, 2025, 3:59 PM
2.46
0.20%
After-hours: Aug 15, 2025, 06:51 PM EDT
C4 Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Cash & Equivalents | 78.16M | 51.29M | 55.5M | 59.65M | 73.11M | 89.66M | 126.59M | 60.97M | 44.88M | 49.48M | 29.75M | 49.55M | 57.3M | 46M | 76.12M | 162.75M | 281.15M |
Short-Term Investments | 136.4M | 163.79M | 189.41M | 195.99M | 190.98M | 168.53M | 127.09M | 155.6M | 222.4M | 220.85M | 246.4M | 264.1M | 250.48M | 245.17M | 233.16M | 239.33M | 184.76M |
Long-Term Investments | n/a | 19.62M | 22.36M | 28.76M | 31.64M | 44.42M | 31.45M | 29.86M | 19.41M | 34.71M | 60.96M | 52.36M | 90.06M | 130.48M | 142.2M | 78.19M | 32.77M |
Other Long-Term Assets | 12.04M | 6.01M | 6.1M | 8.7M | 2.62M | 5.23M | 2.72M | 6.66M | 6.57M | 6.64M | 4.8M | 4.59M | 4.59M | 4.21M | 3.82M | 1.85M | 1.85M |
Receivables | 2.16M | 8.03M | 3.1M | 10.34M | 1.17M | 13.6M | 11.8M | 500K | 1.03M | 528K | 1.47M | 1.49M | 1.71M | 1.77M | 5.72M | 4.84M | 6.21M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -19.41M | -34.71M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 8.02M | 9.42M | 9.76M | 7.25M | 10.78M | 7.8M | 5.71M | 6.62M | 6.07M | 7.6M | 9.93M | 10.31M | 8.88M | 10M | 10.69M | 5.38M | 5.44M |
Total Current Assets | 224.73M | 232.53M | 257.77M | 273.23M | 276.04M | 279.59M | 271.19M | 223.69M | 274.39M | 278.45M | 287.56M | 325.46M | 318.37M | 302.95M | 325.69M | 412.29M | 477.56M |
Property-Plant & Equipment | 59.76M | 61.36M | 63.38M | 65.37M | 67.35M | 69.13M | 71.09M | 72.81M | 74.64M | 76.24M | 77.52M | 79.03M | 79.46M | 77.85M | 35.05M | 15.57M | 16.23M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 71.8M | 86.99M | 91.83M | 102.83M | 105.05M | 118.78M | 105.26M | 109.33M | 100.62M | 117.58M | 143.28M | 135.98M | 174.11M | 212.54M | 181.08M | 95.62M | 50.86M |
Total Assets | 296.53M | 319.52M | 349.6M | 376.06M | 381.09M | 398.37M | 376.45M | 333.01M | 375.01M | 396.04M | 430.84M | 461.44M | 492.48M | 515.49M | 506.76M | 507.91M | 528.42M |
Account Payables | 2.22M | 683K | 1.33M | 1.5M | 913K | 1.63M | 1.45M | 1.28M | 2.25M | 1.03M | 1.17M | 2.37M | 4.45M | 3.4M | 4.51M | 3.75M | 4.47M |
Deferred Revenue | 22.62M | 21.59M | 18.71M | 20.77M | 36.59M | 35.14M | 15.47M | 8.42M | 38.62M | 30.78M | 16.62M | 18.13M | 22.17M | 31.27M | 31.8M | 32.29M | 28.7M |
Short-Term Debt | 6.07M | n/a | n/a | n/a | 5.49M | n/a | 5.22M | 5.09M | 15.29M | 2.29M | 6.99M | 6.83M | 2.57M | 2.48M | n/a | 1.18M | 1.13M |
Other Current Liabilities | 13.55M | 5.07M | 9.3M | 4.51M | 2.07M | 10.26M | 8.07M | 4.42M | 7.54M | 14.22M | 8.24M | 8.02M | 11.41M | 6.27M | 8.52M | 6.85M | 6.05M |
Total Current Liabilities | 44.46M | 40.82M | 45.18M | 43.29M | 54.2M | 55.02M | 42.77M | 30.27M | 48.24M | 39.38M | 44.55M | 45.27M | 46.15M | 46.99M | 51.25M | 48.69M | 44.17M |
Long-Term Debt | 56.86M | n/a | n/a | n/a | 62.92M | n/a | 65.76M | 67.09M | 68.42M | 8.62M | 9.2M | 81.23M | 83.74M | 84.95M | 10.77M | 21.51M | 21.64M |
Other Long-Term Liabilities | 21.15M | 25.12M | n/a | 28.65M | n/a | n/a | -65.76M | -67.09M | -68.42M | n/a | n/a | -72.18M | -73.37M | -74.75M | n/a | -10.92M | -11.23M |
Total Long-Term Liabilities | 78.01M | 83.56M | 88.44M | 90.11M | 79.83M | 85.07M | 87.57M | 86.72M | 93.06M | 94.19M | 97.06M | 97.99M | 101.73M | 103.97M | 65.91M | 60.44M | 67.83M |
Total Liabilities | 122.46M | 124.38M | 133.62M | 133.4M | 134.03M | 140.09M | 130.34M | 116.99M | 141.3M | 133.57M | 141.61M | 143.26M | 147.88M | 150.96M | 117.16M | 109.13M | 111.99M |
Total Debt | 62.92M | 64.37M | 65.76M | 67.09M | 68.42M | 69.72M | 70.98M | 72.18M | 83.71M | 85.45M | 87.15M | 88.06M | 86.32M | 87.42M | 42.88M | 22.68M | 22.77M |
Common Stock | 7K | 7K | 7K | 7K | 7K | 7K | 6K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K |
Retained Earnings | -686.04M | -660.02M | -633.7M | -599.13M | -574.46M | -556.74M | -528.38M | -493.63M | -466.59M | -430.67M | -395.89M | -358.7M | -326.75M | -299.33M | -267.71M | -252.06M | -227.37M |
Comprehensive Income | -30K | 43K | 53K | 455K | -440K | -380K | -127K | -904K | -1.77M | -2.47M | -4.14M | -5.41M | -4.58M | -3.65M | -775K | -155K | -69K |
Shareholders Equity | 174.06M | 195.14M | 215.99M | 242.66M | 247.06M | 258.28M | 246.11M | 216.02M | 233.71M | 262.47M | 289.23M | 318.18M | 344.59M | 364.53M | 389.61M | 398.78M | 416.43M |
Total Investments | n/a | 183.41M | 211.76M | 224.75M | 222.62M | 212.95M | 158.54M | 155.6M | 222.4M | 220.85M | 307.36M | 316.46M | 340.54M | 375.65M | 375.36M | 317.52M | 217.53M |